ropivacaine has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, M; Yu, B; Zhou, Y; Zou, T | 1 |
| Bouaziz, H; Cahn, V; Diarra, DP; Girard, F; Granier, G; Grignon, Y; Iohom, G; Kinirons, BP; Lan, GB; Merle, M | 1 |
2 other study(ies) available for ropivacaine and Nerve Degeneration
| Article | Year |
|---|---|
Morphological changes in the sciatic nerve, skeletal muscle, heart and brain of rabbits receiving continuous sciatic nerve block with 0.2% ropivacaine.
Topics: Amides; Anesthetics, Local; Animals; Brain; Cell Shape; Edema; Heart; Infusions, Parenteral; Male; Motor Activity; Muscle, Skeletal; Myocardium; Necrosis; Nerve Block; Nerve Degeneration; Neurotoxicity Syndromes; Rabbits; Ropivacaine; Sciatic Nerve; Time Factors | 2015 |
Long-term evaluation of motor function following intraneural injection of ropivacaine using walking track analysis in rats.
Topics: Amides; Anesthetics, Local; Animals; Axons; Behavior, Animal; Fibrosis; Formaldehyde; Male; Motor Activity; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Ropivacaine; Schwann Cells; Sciatic Nerve; Walking | 2005 |